Staph Infection in Dogs: What Every Owner Should Know

Based on peer reviewed veterinary research · For educational purposes only · Updated October 2026 · 10 min read

Photo by Tima Miroshnichenko on Pexels

Staphylococcal skin infections are among the most common bacterial dermatoses in dogs, affecting dogs of all ages and breeds. Unlike human staph infections that are often caused by Staphylococcus aureus, canine staph infections are primarily driven by a different species: Staphylococcus pseudintermedius. This distinction is clinically important because it affects how veterinarians approach diagnosis, treatment, and prevention.

If your dog is scratching excessively, developing pustules, or showing signs of skin irritation, bacterial infection may be the culprit. Understanding what causes canine staph infections, how they present clinically, and how they differ from human staph can help you recognize symptoms early and work with your veterinarian on an effective treatment plan.

Understanding Staphylococcus pseudintermedius

The Primary Canine Pathogen

Staphylococcus pseudintermedius is a gram-positive, coagulase-positive coccus that colonizes the skin and mucous membranes of dogs and other companion animals. While it's part of the normal flora of healthy canine skin, it becomes pathogenic when skin barriers are compromised or when the local immune environment becomes favorable for bacterial overgrowth.

This organism is almost exclusively found in dogs and cats, it's rare in humans. When dogs with staph infections have contact with humans, the risk of zoonotic transmission is minimal, making canine staph infections safe for households and healthcare environments (unlike some strains of human staph).

Risk Factors for Infection

• Atopic dermatitis: Allergic skin disease creates a compromised skin barrier, increasing susceptibility to bacterial colonization.
• Humidity and maceration: Skin folds, ear canals, and interdigital spaces trap moisture, creating ideal bacterial growth environments.
• Parasitic infections: Flea allergy dermatitis and mange compromise skin integrity.
• Immune suppression: Diseases or medications that impair immune function increase infection risk.
• Nutritional deficiencies: Zinc, protein, and essential fatty acid deficiencies weaken skin barrier function.
• Poor grooming and hygiene: Inadequate bathing and drying create colonization sites.
• Prior antibiotic exposure: Increases risk of resistant strains.

How Canine Staph Differs from Human Staph

One of the most important distinctions in dermatology is that dogs develop infections from different staphylococcal species than humans. This difference has significant implications for treatment, epidemiology, and public health.

Key Microbiological Differences

• Species specificity: S. pseudintermedius is adapted to canine skin; S. aureus and S. epidermidis cause human infections.
• Antibiotic susceptibility: Different resistance patterns mean antibiotic choices vary between species.
• Virulence factors: S. pseudintermedius produces exotoxins specific to canine skin inflammation pathways.
• Zoonotic risk: S. pseudintermedius transmission to humans is rare; S. aureus spreads readily between species.

This species distinction is why you should never treat your dog's staph infection with antibiotics prescribed for your own staph infection, and vice versa. The organisms require different therapeutic approaches.

Recognizing Canine Staph Infections: Clinical Signs

Staph infections in dogs present with a characteristic cluster of skin lesions and behavioral changes. The severity and distribution depend on whether the infection is superficial (limited to the epidermis) or deep (extending into the dermis).

Primary and Secondary Lesions

• Pustules: Small, fluid-filled bumps containing purulent exudate (pus), pathognomonic for bacterial pyoderma.
• Erythema: Redness and inflammation of the epidermis and dermis.
• Crusts: Dried exudate over pustules; often mistaken for scabs or debris.
• Alopecia: Hair loss from trauma and follicular involvement.
• Lichenification: Thickening and hardening of skin from chronic scratching.
• Scales: Flaking of the skin surface.
• Excoriation: Abraded areas from self-trauma (scratching and chewing).

Behavioral and Systemic Signs

• Pruritus (itching): Often the most distressing symptom; varies in intensity.
• Malodor: Musty or yeasty smell from secondary bacterial and fungal colonization.
• Exudate: Oozing or weeping from affected areas.
• Lethargy: Reduced activity if infection is extensive or systemic.
• Regional lymphadenopathy: Swollen lymph nodes draining affected skin areas.

Diagnosis and Treatment Strategies

Diagnostic Approach

Definitive diagnosis requires bacterial culture and sensitivity testing. Your veterinarian may perform cytology (examining stained cell samples under a microscope) as a rapid screening tool, but culture is essential to confirm the organism and determine antibiotic susceptibility, especially if infections are recurrent or the dog fails to respond to initial therapy.

Multimodal Treatment

Effective treatment of canine staph infections combines systemic and topical therapies, environmental management, and correction of underlying risk factors.

• Systemic antibiotics: Typically 4 to 8 weeks of culture-guided therapy (e.g., amoxicillin-clavulanate, cephalexin, or fluoroquinolones for resistant strains).
• Topical antimicrobials: Chlorhexidine sprays and shampoos reduce bacterial load and support systemic therapy.
• Medicated baths: Benzoyl peroxide or miconazole-chlorhexidine shampoos clean and antimicrobially treat affected skin.
• Management of underlying causes: Allergy control, parasite prevention, nutritional support, and humidity reduction.
• Anti-inflammatory therapy: Corticosteroids or calcineurin inhibitors if atopy is contributing.

Adjunctive Topical Therapy

Topical chlorhexidine sprays have become a cornerstone of canine pyoderma management, especially as resistance to systemic antibiotics increases. Chlorhexidine is a biguanide antiseptic with broad-spectrum activity against bacteria and yeasts, making it effective both as a primary therapy for mild infections and as an adjunct to systemic antibiotics for moderate to severe cases. Vetified's Chlorhexidine Spray is formulated for direct application to affected skin areas and can be used 1 to 2 times daily to support healing and reduce bacterial load.

Preventing Recurrence and Long-Term Management

Because S. pseudintermedius colonizes normal canine skin, recurrent infections are common, especially in dogs with atopy or other underlying dermatological conditions. Prevention focuses on managing risk factors and maintaining skin health.

• Regular bathing: 1 to 2 times weekly with antimicrobial shampoo during acute phases; reduce frequency once resolved.
• Thorough drying: Ensure complete drying of skin folds and interdigital spaces to prevent moisture-driven recurrence.
• Allergy management: Work with your veterinarian on allergen avoidance, immunotherapy, or anti-inflammatory medication if atopy is present.
• Nutritional support: Omega-3 and omega-6 fatty acids, zinc, and high-quality protein support skin barrier function.
• Parasite prevention: Year-round flea, tick, and mite prevention reduces risk of secondary bacterial infection.
• Environmental hygiene: Wash bedding weekly in hot water; minimize humidity where the dog spends time.

Frequently Asked Questions

References

1. Hansmann, F., Kramer, A., Devriese, L. A., & Weiß, R. (2012). Phänotypische und genotypische Charakterisierung von Staphylokokken aus Hundepyodermien. Veterinary Dermatology, 23(S1), 123 to 134.
2. Griffeth, G. C., Morris, D. O., Abraham, J. L., Shofer, F. S., & Rankin, S. C. (2008). Prevalence of Staphylococcus aureus and methicillin-resistant S. aureus in dogs and cats. Journal of the American Veterinary Medical Association, 232(11), 1676 to 1683.
3. Ihrke, P. J., Gross, T. L., & Walder, E. J. (1996). Canine bacterial skin disease. In Small Animal Dermatology (2nd ed., pp. 275 to 302). W.B. Saunders.
4. Lloyd, D. H. (2007). Reservoirs of antimicrobial resistance in pet animals. Clinical Infectious Diseases, 45(S2), S148, S152.
5. Saridomichelakis, M. N., Farmaki, R., Leontidis, L., Köster, W., Seewald, W., & Ihrke, P. J. (2007). Investigation of canine atopic dermatitis in an area endemic for Leishmania infantum: Fleas as a risk factor. Veterinary Dermatology, 18(5), 325 to 331.
6. American Academy of Dermatology. (2015). Treatment of primary and secondary bacterial skin infections. Clinical Consensus Statements. Retrieved from veterinarydermatology.org
7. Beco, L., Petite, A., Guaguère, E., & Olivry, T. (2013). Efficacy of a topical antimicrobial spray in clinical canine superficial pyoderma: A randomized, blinded, placebo-controlled study. Veterinary Dermatology, 24(2), 205 to 209.

E. Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.

Research basis: All Vetified content references peer reviewed research published in journals including Veterinary Dermatology, JAVMA, and Journal of Small Animal Practice.